Skip to main content
OpenTrials

Clinical trial condition

Lupus Erythematosus, Systemic

Explore clinical trials studying Lupus Erythematosus, Systemic. Study availability and eligibility vary by location and protocol.

840 public trials 218 recruiting studies
Refine in advanced search Browse all conditions

Lupus Erythematosus, Systemic trial results

Completed

A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

NCT04294667

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Sl0043 50140 Birmingham, Alabama, United States
  • Sl0043 50052 Phoenix, Arizona, United States
  • Sl0043 50328 Tucson, Arizona, United States
  • Sl0043 50383 Beverly Hills, California, United States
View all 177 locations
View Trial Details
Completed

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus

NCT05155345

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • Pinnacle Research Group Anniston, Alabama, United States
  • ICS ARENSIA Exploratory Medicine Chisinau, Moldova
  • Szpital Uniwersytecki Nr 2 im. Dr Jana Biziela w Bydgoszczy Bydgoszcz, Poland
View Trial Details
Completed

A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE

NCT03312907

Conditions
Autoimmune Diseases, Connective Tissue Diseases, Immune System Diseases, +3 more
Locations
  • GSK Investigational Site Birmingham, Alabama, United States
  • GSK Investigational Site La Mesa, California, United States
  • GSK Investigational Site San Leandro, California, United States
  • GSK Investigational Site Upland, California, United States
View all 79 locations
View Trial Details

Related conditions